ALS (motor neurone disease): open trials in Sweden

• NCT07322003

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

  Trial Treatment · Phase 3 · Prilenia

  Studieenheten Akademiskt specialistcentrum, Stockholm · Umeå University Hospital, Umeå

  Registry updated 2026-10-27

• NCT07023835

  Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

  Trial Treatment · Phase 2 · Zydus Therapeutics Inc.

  Region Skane Skanes Universitetssjukhus, Malmo · Region Stockholm – SLSO, Stockholm · Region Vaesterbotten, Umea

  Registry updated 2026-09-01

• 2025-524002-16-00

  Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)

  Trial Treatment · Phase 3 · Ferrer Internacional S.A.

  Region Stockholm – SLSO, Stockholm · Region Vaesterbotten, Umea

  Registry updated 2026-05-14

• NCT03174938

  The Swedish BioFINDER 2 Study

  Trial Treatment · Phase 2 · Skane University Hospital

  Region Skåne, Malmö

  Registry updated 2026-04-06

• NCT03127267

  Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

  Trial Treatment · Phase 3 · AB Science

  Centralsjukhuset Karlstad (Central Hospital Karlstad), Karlstad · Skåne University Hospital, Malmö · Norrlands universitetssjukhus, Umeå

  Registry updated 2025-09-12

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error